Marc Rothenberg, MD, of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), and Professor of Medicine at Cincinnati Children’s Hospital, gives an overview of eosinophilic esophagitis (EoE).
CEGIR is part of the Rare Diseases Clinical Research Network (RDCRN) consortium.
EoE is a chronic, allergic inflammatory disease characterized by the buildup of eosinophils in the lining of the esophagus. Patients with EoE often experience difficulty feeding, poor weight gain, and trouble swallowing.
Currently, there is no approved treatment specifically for EoE. Most patients try to adhere to a strict diet that avoids food groups that may trigger an EoE episode.
Recently, the CERIG group published their study in the Lancet Gastroenterology & Hepatology journal showing that the elimination of milk from the diet was as effective as adhering to a more strict six-food elimination diet (animal milk, wheat, egg, soy, fish and shellfish, and peanut and tree nuts).
To learn more about the research being conducted by CEGIR, visit cegir.rarediseasesnetwork.org/
To stay up to date on the latest clinical research by CEGIR and other RDCRN consortia, visit checkrare.com/rare-diseases-clinical-research-network/
